Xponance’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.28M Sell
16,567
-10,890
-40% -$794K 0.01% 709
2026
Q1
$1.79M Buy
27,457
+3,410
+14% +$253K 0.01% 591
2025
Q4
$1.91M Buy
24,047
+1,269
+6% +$97.2K 0.01% 550
2025
Q3
$1.66M Buy
22,778
+662
+3% +$48.5K 0.01% 586
2025
Q2
$1.68M Buy
22,116
+871
+4% +$61.7K 0.01% 570
2025
Q1
$1.62M Buy
21,245
+231
+1% +$17.2K 0.02% 568
2024
Q4
$1.39M Buy
21,014
+1,879
+10% +$132K 0.01% 617
2024
Q3
$1.33M Sell
19,135
-738
-4% -$44.4K 0.01% 630
2024
Q2
$1.05M Buy
+19,873
New +$1.21M 0.01% 665

Other funds holding SOLV

Xponance's SOLV Position: Q2 2026 in Review

Xponance reduced its Solventum (SOLV) stake by 40% in Q2 2026, selling an estimated $794K and leaving 16,567 shares worth $1.28M. The position accounts for 0.01% of the portfolio, ranked #709.

Xponance first reported a position in SOLV in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.91M in Q4 2025. 878 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Xponance held 16,567 shares of Solventum worth $1.28M as of Q2 2026.
  • Xponance sold 10,890 Solventum shares in Q2 2026, an estimated $794K.
  • Solventum made up 0.01% of Xponance's portfolio in Q2 2026, its #709 holding.
  • Xponance first reported a position in Solventum in Q2 2024 and has held it in 9 quarters since.
  • Xponance's Solventum position peaked at $1.91M in Q4 2025.
  • 878 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.